GregFolin

$TEVA Catches Fresh Momo as Malaria Drugs Get the Nod

NYSE:TEVA   Teva Pharmaceutical Industries Limited
TEVA shares are popping to start off the week as the company gets into the middle of the chloroquine emphasis to battle the COVID-19 outbreak. The longer-term picture is defined by the potential for fresh momentum after successfully holding key support.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.